deltatrials
Active Not Recruiting OBSERVATIONAL NCT06129084

A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing

ctDNA-FGFR Status as a Predictive Biomarker for FGFR Targeted Therapy

Sponsor: Bernie Eigl

Conditions Metastatic Bladder Cancer Metastatic Urothelial Carcinoma
Interventions FGFR Testing
Updated 6 times since 2023 Last updated: Dec 8, 2025 Started: Jan 11, 2021 Primary completion: Sep 15, 2025 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Metastatic Bladder Cancer and Metastatic Urothelial Carcinoma and is currently ongoing. Bernie Eigl leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Sep 2025 · 10 months · monthly snapshotRecruiting~Sep 2025 – ~Jan 2026 · 4 months · monthly snapshotRecruiting~Jan 2026 – present · 6 months · monthly snapshotActive Not Recruiting

Change History

6 versions recorded

  1. Jan 2026 — Present [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  2. Sep 2025 — Jan 2026 [monthly]

    Recruiting

  3. Nov 2024 — Sep 2025 [monthly]

    Recruiting

  4. Sep 2024 — Nov 2024 [monthly]

    Recruiting

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting

▶ Show 1 earlier version

  1. Dec 2023 — Jul 2024 [monthly]

    Recruiting

    First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bernie Eigl
  • Bladder Cancer Canada
  • Lady Davis Institute
  • Vancouver Prostate Centre
Data source: British Columbia Cancer Agency

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations